Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Polygenic or Pollyanna?

Nature Medicine volume 8, pages 328–330 (2002)Cite this article

A study suggesting that many genes, each conferring a small risk, account for most cases of breast cancer could have important implications for population-based prevention programs—provided that the genes can be identified.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Different models of the distribution of breast-cancer risk in the population and in breast cancer cases.

References

  1. Pharoah, P.D.P. et al. Polygenic susceptibility to breast cancer and implications for prevention. Nature Genet. 30 (2002); advance online publication, 4 March 2002 (DOI: 10.10138/ng853).

  2. Antoniou, A.C. et al. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet. Epidemiol. 21, 1–18 (2001).

    Article  CAS  Google Scholar 

  3. Lichtenstein, P. et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark and Finland. N. Engl. J. Med. 343, 78–85 (2000).

    Article  CAS  Google Scholar 

  4. Easton, D.F. How many more breast cancer predisposition genes are there? Breast Cancer Res. 1, 14–17 (1999).

    Article  CAS  Google Scholar 

  5. Chenevix-Trench, G. et al. Dominant Negative ATM Mutations in Breast Cancer Families. J. Natl. Cancer Inst. 94, 205–215 (2002).

    Article  Google Scholar 

  6. Elhaji, Y.A. et al. The polymorphic CAG repeat of the androgen receptor and female breast cancer. Am. J. Hum. Genet. 61S, abstract 64 (1997).

    Google Scholar 

  7. Rebbeck, T.R. et al. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen receptor CAG repeat. Am. J. Hum. Genet. 64, 1371–1377 (1999).

    Article  CAS  Google Scholar 

  8. Giguère, Y. et al. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population. Cancer Res. 61, 5869–5874 (2001).

    PubMed  Google Scholar 

  9. Haiman, C.A. et al. The androgen receptor CAG repeat polymorphisms and risk of breast cancer in the Nurses' Health Study. Cancer Res. 62, 1045–1049 (2002).

    CAS  PubMed  Google Scholar 

  10. Yu, H. et al. Shorter CAG repeat length in the androgen receptor gene is associate with more aggressive forms of breast cancer. Breast Cancer Res. Treat. 59, 153–161 (2000).

    Article  CAS  Google Scholar 

  11. Elhaji, Y.A. et al. The polymorphic CAG repeat of the androgen receptor gene: a potential role in breast cancer in women over 40. Breast Cancer Res. Treat. 70, 109–116 (2001).

    Article  CAS  Google Scholar 

  12. Dunning, A. et al. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol. Biomark. Prevent. 8, 843–854 (1999).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Program in Cancer Genetics McGill University, Montreal, Quebec, Canada

    William D. Foulkes

Authors
  1. William D. Foulkes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Foulkes, W. Polygenic or Pollyanna?. Nat Med 8, 328–330 (2002). https://doi.org/10.1038/nm0402-328

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0402-328

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing